Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studies.
Yang S, Wu S, Zhao Y, Chen G, Zhu B, Li X, Wang K, Shi J, Cang S, Yao W, Fan Y, Fang J, Zhang L, Zhou J, Wu L, Zheng R, Huang M, Pan Y, Yang Z, Sun M, Yu H, Wang D, Huang J, Wang L, Shu Y, Chen Z, Liu C, Li J, Liu J, Sun S, Guo Y, Meng Z, Liu Z, Han Z, Wu G, Lu H, Ma R, Hu S, Zhao G, Zhang L, Liu Z, Xie C, Zhong D, Zhao H, Bi M, Yi S, Guo S, Yi T, Li W, Lin Y, Chen Z, Zhuang Z, Guo Z, Greco M, Wang T, Zhou A, Shi Y. Yang S, et al. Among authors: yi s, yi t. Lung Cancer. 2023 Jun;180:107194. doi: 10.1016/j.lungcan.2023.107194. Epub 2023 Apr 17. Lung Cancer. 2023. PMID: 37163774 Free article.
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study.
Shi Y, Wu S, Wang K, Cang S, Yao W, Fan Y, Wu L, Huang M, Li X, Pan Y, Yang Z, Zhu B, Chen G, Shi J, Sun M, Fang J, Wang L, Chen Z, Liu C, Li J, Liu J, Sun S, Zhao Y, Guo Y, Meng Z, Liu Z, Han Z, Lu H, Ma R, Hu S, Zhao G, Liu Z, Xie C, Zhong D, Zhao H, Yu H, Zhang L, Bi M, Yi S, Guo S, Yi T, Li W, Lin Y, Shu Y, Chen Z, Guo Z, Greco M, Wang T, Shen H. Shi Y, et al. Among authors: yi s, yi t. J Thorac Oncol. 2022 Nov;17(11):1306-1317. doi: 10.1016/j.jtho.2022.08.015. Epub 2022 Aug 29. J Thorac Oncol. 2022. PMID: 36049654 Free article. Clinical Trial.
[Long-term follow-up of multiple myeloma after autologous hematopoietic stem cell transplantation: a single center results].
Sui WW, Zou DH, An G, Yi SH, Deng SH, Huang WY, Wang TY, Li J, Liu H, Fu MW, Lyu R, Liu W, Xu Y, Li ZJ, Zhao YZ, Qiu LG. Sui WW, et al. Among authors: yi sh. Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):499-504. doi: 10.3760/cma.j.issn.0253-2727.2017.06.007. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 28655093 Free PMC article. Chinese.
[Clinical analysis of fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of 43 cases of chronic lymphoblastic leukemia].
Wang TY, Yi SH, Wang Y, Lyu R, Wang Q, Deng SH, Sui WW, Fu MW, Huang WY, Liu W, An G, Zhao YZ, Qiu LG. Wang TY, et al. Among authors: yi sh. Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):543-548. doi: 10.3760/cma.j.issn.0253-2727.2021.07.003. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34455740 Free PMC article. Chinese.
[Clinical features and outcomes of newly diagnosed follicular lymphoma concurrent with diffuse large B-cell lymphoma component].
Lin ZJ, Zha J, Yi SH, Li ZF, Ping LY, He XH, Yu HF, Zheng Z, Xu W, Chen FL, Xie Y, Chen BY, Zhang HL, Wang L, Ding KY, Li WY, Yang HY, Zhao WL, Qiu LG, Li ZM, Song YQ, Xu B. Lin ZJ, et al. Among authors: yi sh. Zhonghua Xue Ye Xue Za Zhi. 2022 Jun 14;43(6):456-462. doi: 10.3760/cma.j.issn.0253-2727.2022.06.003. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35968587 Free PMC article. Chinese.
[Dose-enhanced immunochemotherapy followed by first-line autologous peripheral blood stem cell transplantation for young patients with high-risk aggressive B-cell lymphoma: an efficacy and prognostic factor analysis].
Wang Y, Liu W, Huang WY, Lyu R, Li J, Deng SH, Sui WW, Liu H, Wang TY, Yi SH, Liu HM, Qiu LG, Zou DH. Wang Y, et al. Among authors: yi sh. Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):215-220. doi: 10.3760/cma.j.issn.0253-2727.2022.03.006. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35405779 Free PMC article. Chinese.
[Analysis of the clinical characteristics and prognosis of 20 patients with multicenter Castleman disease].
Fan HS, Yan WW, Xu JY, Liu JH, Du CX, Sui WW, Deng SH, Liu W, Yi SH, Huang WY, Xu Y, Zhao YZ, Qiu LG, Zou DH, An G. Fan HS, et al. Among authors: yi sh. Zhonghua Xue Ye Xue Za Zhi. 2021 Jun 14;42(6):510-513. doi: 10.3760/cma.j.issn.0253-2727.2021.06.012. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34384159 Free PMC article. Chinese. No abstract available.
4,316 results